Comparison of the SUpera® PERipheral System to a Performance Goal derived from Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery (The SUPERB Study)Carotid Trial

Trial Conditions

Superficial Femoral Artery Disease

What is the purpose of this trial?

To demonstrate the safety and effectiveness of the IDEV Supera Nitinol Stent System in treating subjects with obstructive superficial femoral artery disease. The primary endpoint will be the primary patency rate greater than 66% at 12 months.